Different sensitivity of ATP + Mg + Na (I) and Pi + Mg (II) dependent types of ouabain binding to phospholipase A2

. 1988 Sep ; 104 (3) : 211-21.

Jazyk angličtina Země Spojené státy americké Médium print

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid02850363

The effect of phospholipase A2 and of related agents on ouabain binding and Na, K-ATPase activity were studied in intact and detergent-treated membrane preparations of rat brain cortex and pig kidney medulla. It was found that phospholipase A2 (PLA2) may distinguish or dissociate ouabain binding complexes I (ATP + Mg + Na) and II (Pi + Mg), stimulating the former and inhibiting the latter. Procedures which break the permeability barriers of vesicular membrane preparations, such as repeated freezing-thawing, sonication or hypoosmotic shock failed to mimic the effect of PLA2, indicating that it was not acting primarily by opening the inside-out oriented vesicles. The detergent digitonin exhibited similar effects on ouabain binding in both ATP + Mg + Na and Pi + Mg media. Other detergents were ineffective. The ability of PLA2 to distinguish between ouabain binding type I and II can be manifested even in SDS-treated, purified preparations of Na, K-ATPase. The number of ATP + Mg + Na-dependent sites is unchanged, while the Pi + Mg-dependent sites are decreased in number in a manner similar to that seen in original membranes. This inhibition is completely lost in the reconstituted Na, K-ATPase system, where the ATP- as well as Pi-oriented ouabain sites are inhibited by PLA2.

Zobrazit více v PubMed

J Biol Chem. 1953 Jun;202(2):675-85 PubMed

Q Rev Biophys. 1974 May;7(2):239-74 PubMed

Life Sci. 1981 Nov 30;29(22):2235-47 PubMed

J Biol Chem. 1973 Feb 10;248(3):867-74 PubMed

Biochim Biophys Acta. 1973 Dec 22;330(3):316-24 PubMed

Biochem Pharmacol. 1984 Nov 15;33(22):3649-54 PubMed

J Physiol. 1981 Mar;312:505-29 PubMed

Biochim Biophys Acta. 1978 Apr 20;508(3):486-99 PubMed

Biochemistry. 1980 Mar 4;19(5):969-77 PubMed

Eur J Biochem. 1973 Dec 3;40(1):245-57 PubMed

Biochem Pharmacol. 1981 Mar 1;30(5):427-32 PubMed

J Biol Chem. 1985 Sep 25;260(21):11508-13 PubMed

Nature. 1985 Aug 22-28;316(6030):691-5 PubMed

Biochem Pharmacol. 1978 Jan 15;27(2):225-31 PubMed

J Membr Biol. 1982;69(1):65-76 PubMed

J Neurochem. 1962 Jan-Feb;9:23-35 PubMed

Neurochem Int. 1986;8(4):449-76 PubMed

Mol Pharmacol. 1973 May;9(3):350-9 PubMed

Biochim Biophys Acta. 1983 Mar 23;729(1):75-84 PubMed

Experientia. 1986 Apr 15;42(4):405-7 PubMed

Biochem J. 1978 Feb 1;169(2):313-20 PubMed

Mol Pharmacol. 1968 Jul;4(4):324-36 PubMed

Biometrics. 1981 Jun;37(2):235-49 PubMed

Biochim Biophys Acta. 1974 Jul 12;356(1):36-52 PubMed

J Biol Chem. 1960 Nov;235:3322-9 PubMed

Biochim Biophys Acta. 1971 Apr 13;233(2):366-80 PubMed

Eur J Biochem. 1975 Oct 15;58(2):595-601 PubMed

Toxicon. 1982;20(2):409-17 PubMed

Biochemistry. 1977 Feb 8;16(3):531-40 PubMed

Z Naturforsch C. 1979 Dec;34(12 ):1224-31 PubMed

J Biol Chem. 1982 Nov 10;257(21):12678-84 PubMed

J Biol Chem. 1980 Oct 25;255(20):9971-80 PubMed

J Biol Chem. 1979 Jul 10;254(13):6060-7 PubMed

J Gen Physiol. 1976 May;67(5):497-525 PubMed

J Biol Chem. 1974 Feb 25;249(4):1071-80 PubMed

J Biol Chem. 1973 Feb 25;248(4):1291-300 PubMed

Biochim Biophys Acta. 1977 Feb 14;465(1):77-92 PubMed

J Gen Physiol. 1976 May;67(5):527-45 PubMed

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...